BRIEF published on 01/31/2025 at 12:15, 1 year 7 months ago Marinomed Biotech AG Announces Management Board Changes CFO Resignation Marinomed Biotech AG Financial Restructuring Management Changes Marinosolv Platform
PRESS RELEASE published on 01/31/2025 at 12:10, 1 year 7 months ago Marinomed Biotech AG: Changes to the Management Board Marinomed Biotech AG announces CFO resignation and appointment of interim finance manager. Successful completion of restructuring and securing financing by selling Carragelose business unit Restructuring CFO Resignation Marinomed Biotech AG Carragelose Interim Finance Manager
BRIEF published on 01/20/2025 at 07:50, 1 year 7 months ago Marinomed Biotech AG Completes Restructuring Proceedings Restructuring Insolvency Business Sale Marinomed Biotech Creditor Approval
BRIEF published on 01/20/2025 at 07:50, 1 year 7 months ago Marinomed Biotech AG achève sa restructuration Restructuration Insolvabilité Vente D'entreprise Biotechnologie Marinomed Approbation Du Créancier
PRESS RELEASE published on 01/20/2025 at 07:45, 1 year 7 months ago Marinomed Biotech AG: Restructuring proceedings successfully completed Marinomed Biotech AG successfully completes restructuring proceedings, fulfilling plan to be funded by Carragelose business sale and Marinosolv asset commercialization Commercialization Marinomed Biotech AG Carragelose Restructuring Proceedings Marinosolv Asset
BRIEF published on 12/19/2024 at 12:44, 1 year 8 months ago Marinomed Biotech AG approuve la vente de sa division Carragelose Marinomed Biotech AG Orientation Stratégique Changements Au Sein Du Conseil D'administration Approbation De La Vente Division De Carragelose
BRIEF published on 12/19/2024 at 12:44, 1 year 8 months ago Marinomed Biotech AG Approves Sale of Carragelose Division Board Changes Strategic Focus Marinomed Biotech AG Sale Approval Carragelose Division
PRESS RELEASE published on 12/19/2024 at 12:39, 1 year 8 months ago Marinomed Biotech AG: Extraordinary general meeting approves sale of Carragelose division Marinomed Biotech AG's extraordinary general meeting approves sale of Carragelose division, ensuring implementation of restructuring plan. Dr. Karl Mahler elected to the Supervisory Board Supervisory Board Marinomed Biotech AG Restructuring Plan Sale Approval Carragelose Division
BRIEF published on 12/17/2024 at 13:05, 1 year 8 months ago Marinomed Biotech AG franchit une étape importante dans sa restructuration Obligation Convertible Financement Des Biotechnologies Vente De Carraghénose Restructuration De Marinomed Accord BEI
BRIEF published on 12/17/2024 at 13:05, 1 year 8 months ago Marinomed Biotech AG Achieves Restructuring Milestone Convertible Bond Carragelose Sale Marinomed Restructuring EIB Agreement Biotech Finance
Published on 09/01/2026 at 12:00, 20 minutes ago NuRAN Wireless Advances Edge AI Infrastructure Strategy for Rural Connectivity Sites in Africa
Published on 09/01/2026 at 12:00, 20 minutes ago Pivotree Announces Normal Course Issuer Bid For Common Shares
Published on 09/01/2026 at 11:30, 50 minutes ago FireFox Gold Drills Downdip Extension of East Zone, including 1.0m at 124 g/t Au at the Mustajärvi Project in Lapland, Finland
Published on 09/01/2026 at 10:00, 2 hours 20 minutes ago Eagle Plains' Partner Xcite Uranium Commences Drill Program at the Lorado Uranium Project, Saskatchewan
Published on 09/01/2026 at 01:39, 10 hours 41 minutes ago GLG Life Tech Corporation Reports 2026 Second Quarter Financial Results
Published on 09/01/2026 at 12:05, 15 minutes ago THE WORLD'S 50 BEST HOTELS 2026 ANNOUNCES THE EXTENDED 51-100 LIST
Published on 09/01/2026 at 11:00, 1 hour 20 minutes ago Romande Energie accelerates progress towards its target of 5 TWh of low-carbon power generation with the construction of a new wind farm in France
Published on 09/01/2026 at 11:00, 1 hour 20 minutes ago Romande Energie accélère sa trajectoire vers 5 TWh de production sous gestion avec la construction d'un nouveau parc éolien en France
Published on 09/01/2026 at 10:45, 1 hour 35 minutes ago Cloover reaches profitability at $350M run-rate as it launches AI-native neo-utility
Published on 09/01/2026 at 10:05, 2 hours 15 minutes ago Dublin-born composer silenced by the Nazis returns to Vienna's Musikverein
Published on 08/31/2026 at 18:00, 18 hours 20 minutes ago MISE A DISPOSITION RAPPORT FINANCIER ANNUEL 2025/2026
Published on 08/31/2026 at 17:45, 18 hours 35 minutes ago Disclosure of transactions in own shares from August 24 to August 28, 2026
Published on 08/31/2026 at 17:45, 18 hours 35 minutes ago Déclaration hebdomadaire d'opérations effectuées du 24 au 28 août 2026
Published on 08/31/2026 at 17:45, 18 hours 35 minutes ago Déclaration hebdomadaire de rachat d'actions
